ClinicalTrials HQ

A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours

A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours

Recruiting · NCT07213817 · Registry updated 2026-10-01
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid TumoursNeoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasmRecruitingPhase 1 / Phase 22026-10-01NCT07213817

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Ipsen59

12 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Centre Leon BerardLyonFrance34
Gustave Roussy Cancer Campus Grand Paris- (Institut de Cancerologie Gustave-Roussy)VillejuifFrance2
Hospital Universitari Vall d'HebronBarcelonaSpain45
Institut de Cancerologie de l'Ouest (ICO)- CRLCC Rene GauducheauSaint-HerblainFrance1
MD Anderson Cancer CenterHoustonUnited States589
NEXT OncologySan AntonioUnited States70
NEXT OncologyFairfaxUnited States31
NEXT Quiron-BarcelonaBarcelonaSpain2
Sidney Kimmel Cancer CenterPhiladelphiaUnited States4
START Madrid CIOCC Hospital Universitario HM SanchinarroMadridSpain1
START MidwestGrand RapidsUnited States79
Yale Cancer Center-Yale UniversityNew HavenUnited States1